Cell Therapeutics Management Discusses Q2 2012 Results - Earnings Call Transcript

Cell Therapeutics (CTIC)

Q2 2012 Earnings Call

August 01, 2012 8:30 am ET

Executives

James A. Bianco - Principal Founder, Chief Executive Officer, President and Executive Director

Louis A. Bianco - Co-Founder, Principal Financial Officer, Principal Accounting Officer, Executive Vice President - Finance and Administration and Secretary

Steven E. Benner - Chief Medical Officer and Executive Vice President

Analysts

Michael G. King - Rodman & Renshaw, LLC, Research Division

Presentation

Operator

Ladies and gentlemen, thank you for standing by. Welcome to the Cell Therapeutics Q2 Financial Results Call on the 1st of August, 2012. [Operator Instructions] I would now like to hand the conference over to Dr. James Bianco, President and CEO. Please go ahead, sir.

James A. Bianco

Good morning. Thank you for joining us today. Before I get started, I'd like to remind you, as is common with presentations of this type, that we'll be making forward-looking statements, and as such, I recommend you refer to our SEC filings for more information on the company.

Let me also remind you that this call is recorded and be available for playback on our website. Any unauthorized recording of this call or use of this recording is prohibited without written consent of the company.

So on today's call, we're going to review the financial results for the second quarter, update you on our prelaunch activities and in-market research on a potential commercial opportunity on Pixuvri, talk about the status of the pacritinib Phase III program and review the strategy for tosedostat and briefly discuss the activities on OPAXIO and brostallicin. Let me start with the financial results for the second quarter.

If you liked this article you might like

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

2016 Was a Terrible Year for Biotech but the Tweets Were on Point

Gilead Sciences' Next Challenge to Incyte's Myelofibrosis Drug Dominance

Insider Trading Alert - LPNT, PATK And CTIC Traded By Insiders

Insider Trading Alert - SPTN, FL And CTIC Traded By Insiders